Rosacea is a common chronic inflammatory dermatosis affecting the central face, characterized by intermittent periods of exacerbation and remission. It affects both sexes, and it typically presents after 30 years of age [1-3]. Reported prevalence rates of rosacea range from 0.09 % to 10 % [4]. A Greek study reported a prevalence of 1.22 %, with 0.88 % prevalence for ETT and 0.34 % for PPR [3].
CITATION STYLE
Dessinioti, C., & Antoniou, C. (2014). Systemic treatment of rosacea. In Pathogenesis and Treatment of Acne and Rosacea (Vol. 9783540693758, pp. 699–705). Springer-Verlag Berlin Heidelberg. https://doi.org/10.1007/978-3-540-69375-8_93
Mendeley helps you to discover research relevant for your work.